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Volume 59, Number 6S Abstracts 15SResults: Ninety-seven limbs were treated with DEB
for intermittent claudication (IC, n ¼ 8 [8%]) or critical
limb ischemia (CLI; n ¼ 89 [92%]) in 88 patients. Lesions
were de novo (n ¼ 37 [38%]) or restenosis (n ¼ 60 [64%],
with n ¼ 41 [68%] ISR). Overall PP rate was 77.2% and
57.8% at 6 and 12 months. PP rate of de novo group
was signiﬁcantly (P < .05) higher compared with the reste-
nosis group after 6 (94.5% vs 77.2%) and 12 months
(85.1% vs 57.8%). After 12 months secondary TLR was
signiﬁcantly higher in RE (23.7% vs 4.1% in DN; P <
.001). Sustained clinical improvement was 79.4% in RE
and 66.7% in DE (P ¼ .34).
Conclusions: DEB is an effective therapy for femoro-
popliteal lesions. The results of DEB for restenosis are infe-
rior compared with de novo stenosis. Nevertheless,
outcomes after DEB for restenosis seem to be comparable
with technically more demanding ISR strategies.
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Thoracic Outlet Syndrome
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Objectives: There are no deﬁned criteria for the de-
gree of venous compression leading to venous thoracic
outlet syndrome (vTOS). Our goal was to evaluate the re-
lationships between subclavian vein stenosis and symptoms
in vTOS using contrast venography and intravascular ultra-
sound (IVUS).
Methods: Subclavian veins of consecutive patients
presenting with vTOS were evaluated by venography and
IVUS in the index and contralateral limbs. Venograms
were classiﬁed as normal, stenotic, or occluded. Venogram
and IVUS measurements were made at two locations:
lateral margin of the ﬁrst rib (S1) and site of maximal
compression (S2). Venography provided cranial-caudal
(CC) dimensions. IVUS measurements included: ante-
rior-posterior, CC dimensions (mm), and cross-sectional
area (mm2). The ratio of these determined percentage of
stenosis. Postoperatively, limbs were reevaluated by venog-
raphy and IVUS.
Results: Forty-ﬁve limbs from 23 patients were evalu-
ated. Twenty-three limbs underwent TOS decompression
and were evaluated postoperatively. IVUS and venogram
data are presented in the Table.
Conclusions: vTOS symptoms are related to the pres-
ence of high-grade stenosis and best deﬁned by IVUS.
Asymptomatic patients demonstrate unexpected luminal
reduction, which appears nonpathologic. Compared with
venography, IVUS provides a more detailed evaluation
of the subclavian vein. The greatest change in venous
dimension by IVUS is in the anterior-posterior plane and
is not seen on venography. IVUS offers the potential to
reﬁne criteria identifying critical stenosis at the thoracic
outlet.Table. Venogram and intravascular ultrasound (IVUS)
data for all subjects presenting with venous thoracic
outlet syndrome (vTOS) symptoms
Pre-op Post-op Post-opPatients (No.)Pre-op venogram IVUS venogram IVUSReading
CC
Stenosis (%)Area
stenosis (%)CC
Stenosis (%)Area
stenosis (%)Symptomatic
3 Normal 24.1 54.0 N/A N/A
12 Stenotic 39.0 81.1 31.2 40.3
11 Occluded 100 100 34.9 57.1Asymptomatic
11 Normal 8.4 59.0 N/A N/A
8 Stenotic 48.7 72.6 N/A N/AAuthor Disclosures: B. G. DeRubertis: Nothing to
disclose; S. M. Farley: Nothing to disclose;H. A. Gelabert:
Nothing to disclose; J. C. Jimenez: Nothing to disclose;
S. C. Kiang: Nothing to disclose; J. B. O’Connell:
Nothing to disclose; D. A. Rigberg: Nothing to disclose;
J. Yang: Nothing to disclose.
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Objectives: The impact of anatomic suitability for endo-
vascular aneurysm repair (EVAR) as it relates to mortality for
ruptured abdominal aortic aneurysm (rAAA) is unknown.We
reviewed our experience managing rAAA patients with
emphasis onEVARcandidacy as it relates to 30-daymortality.
Methods: This study included all patients with rAAA
between January 1, 2002, and October 31, 2013 from a
single institution. All images were reviewed by a physician
blinded to outcome/procedure with speciﬁc notation
made on EVAR candidacy (aortic neck diameter and
length). Data were compared using Pearson c2 with signif-
icance set at P < .05.
Results: Of 303 patients with rAAA, 235 (78%) had a
computed tomography scan, 215 were “evaluable,” and
156 (73%) were considered EVAR candidates. Mean aneu-
rysm diameter, aortic neck diameter, and length were 82.4
mm (range, 37-182 mm), 26.7 mm (range, 15-65 mm),
and 17.2 (range, 0-105 mm). The Table shows 30-day
mortality by procedure and EVAR candidacy. For patients
undergoing EVAR, EVAR candidates had a signiﬁcant sur-
vival advantage (77.6% vs 0%; P ¼ .0001). For patients un-
dergoing open repair, there was no difference in mortality
based on EVAR candidacy (49.2% vs 46.9%; P ¼ .82).
Conclusions: Candidates for EVAR who undergo
EVAR for rAAA have a signiﬁcant survival advantage
over those undergoing open repair and those undergoing
EVAR without suitable anatomy. Mortality for any open
repair is high and does not differ based on EVAR candi-
dacy. Those patients with anatomy unsuitable for EVAR
should not undergo an attempt at endovascular repair
because the result is uniformly fatal at 30 days.
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candidacy for endovascular aneurysm repair (EVAR)a
Variable No. (%) 30-day mortality, %Candidates for EVAR
EVAR 85 (54) 22.4
Open 71 (46) 49.2
Total 156
P .0007Not candidates for EVAR
EVAR 5 (9) 100
Open 49 (91) 46.9
Total 54
P .024a15 patients died before open repair.
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Objectives: In 2008, our division’s 5-year strategic
plan prioritized three programs. The top priority was,
“To become an internationally recognized center of excel-
lence for endovascular treatment of complex aortic pathol-
ogy extending from aortic valve to external iliac artery.”
Methods: We identiﬁed four key components to
achieve this strategic priority: (1) training at centers of
excellence (COE) in complex endovascular repair, (2) in-
dustry partnership to improve access to developing tech-
nologies, (3) prospective data collection, (4) development
and implementation of a physician-sponsored IDE for jux-
tarenal, pararenal, and thoracoabdominal aneurysms.
Results: After completing training at COEs and devel-
oping industry partnerships, our ﬁrst complex endovascular
aortic repair (deﬁnition: including 1 or more fenestration/
branch) was done in 2010. We have now performed 45 re-
pairs (15 commercially manufactured devices, 30 physician-
modiﬁed devices) for 3 common iliac, 20 juxtarenal, 8 par-
arenal, and 14 thoracoabdominal aneurysms. The repairs
incorporated 112 fenestrations/16 scallops; 94 (73%)
were bridged to a target vessel with a stent graft. All pa-
tients had complete 30-day follow-up for calculation of
30-day event rates: 2 (4.4%) mortality, 2 (4.4%) progres-
sion to dialysis, 8 (18%) access complications, 2 (4.4%)
type I or III endoleaks, and no instances of myocardial
infarction, bowel ischemia, paraplegia, paralysis, or stroke.
With this experience, we submitted a physician-sponsored
IDE to the Food and Drug Administration to evaluate
safety/efﬁcacy of physician-modiﬁed endografts for com-
plex aortic aneurysms in the fall of 2013 and obtained
approval on 30-day review.Conclusions: In 5 years, we developed a successful
complex endovascular aortic program that uses fenestrated
and branch repair techniques. Focused strategic planning
and a team approach to program development is an effec-
tive way for vascular surgery divisions to gain experience
and expertise with new complex technologies while
ensuring acceptable patient outcomes.
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Objectives: Current risk-prediction models for
abdominal aortic aneurysm (AAA) repair are suboptimal
and infrequently used. This study aimed to develop a reli-
able model for in-hospital mortality after AAA intervention
using data from the United Kingdom National Vascular
Database (UK NVD), applying rigorous and contemporary
statistical techniques to handle missing data.
Methods: UK NVD data for AAA interventions over a
15-month period (Feb 2010-Apr 2011) were analyzed. Mul-
tiple imputation methodology was applied to handle missing
data, and stepwise minimization of the Schwarz-Bayes crite-
rion was used to select optimal models of in-hospital mortal-
ity after AAA repair using (A) preoperative variables only or
(B) preoperative and perioperative variables. Two-thirds of
the data were used as the “modeling set,” with the remaining
third used as the “validation set.” Model performance was
assessed using receiver operating characteristic (ROC) curve
analysis, and compared with existing risk-prediction models.
Results: During the study period, 8088 AAA proce-
dures were recorded in the NVD, of which 5872 (72.6%)
were elective. Model A (9 variables) and B (10 variables)
showed excellent discrimination, with areas under the ROC
curve (AUC) of 0.89 and 0.92, respectively, for all AAA pro-
cedures. Separate models for endovascular/open or elective/
emergency interventions were not necessary, because a single
model (with type of repair and mode of admission as input
variables) performed better. Discrimination remained excel-
lent when considering only elective procedures (AUC 0.82
and 0.85) and was signiﬁcantly better than existing models
(model A, P < .001; model B, P ¼ .001).
Conclusions: The United Kingdom Aneurysm Risk
Model appears accurate and outperformed all existing tools
in this study. After further validation, the model could be
invaluable both for preoperative patient counseling and
accurate risk adjustment of published outcome data.
